· Weekly signal · GH

Guardant Health Inc (GH) lifts four-week run to 38.7%

The precision-oncology diagnostics stock remains in constructive weekly context, though confirmation is not uniform.

Guardant Health diagnostics lab scene with blood testing equipment and market data display.

Guardant Health Inc (GH) closed the latest week at 131.62 USD, rising 4.8% as the Healthcare name extended its recent advance.

The weekly price path over 52 weeks shows an active trend, with the move supported by positive Market Dynamics. The setup is still mixed because Relative Strength is moderate and volume trailed its recent weekly average.